Neuromed Pharmaceuticals Ltd.

Canada

Commandez votre montre hebdomadaire Neuromed Pharmaceuticals Ltd.
Quantité totale PI 10
Rang # Quantité totale PI 157 196
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 705 386

Brevets

Marques

0 0
0 0
10 0
0
 
Dernier brevet 2013 - Substituted aryl sulfone derivat...
Premier brevet 2005 - N-type calcium channel blockers

Derniers inventions, produits et services

2012 Invention Substituted aryl sulfone derivatives as calcium channel blockers. A series of substituted aryl s...
2008 Invention Substituted aryl sulfone derivatives as calcium channel blockers. A series of substituted aryl su...
Invention Amino acid derivatives as calcium channel blockers. Methods and compounds effective in ameliorati...
Invention Bicyclic pyrimidine derivatives as calcium channel blockers. Methods and compounds effective in a...
Invention Amide derivatives as calcium channel blockers. Methods and compounds effective in ameliorating co...
2007 Invention Cyclopropyl-piperazine compounds as calcium channel blockers. Methods and compounds effective in ...
Invention Diaryl piperidine compounds as calcium channel blockers. Methods and compounds effective in ameli...
Invention Heterocyclic compounds as calcium channel blockers. Methods and compounds effective in ameliorati...
Invention Method for increasing the bioavailability of benzhydryl piperazine containing compounds. A method...
Invention Isoxazole derivatives as calcium channel blockers. Methods and compounds effective in amelioratin...
2006 Invention Heterocyclic amide derivatives as calcium channel blockers. Methods and compounds effective in am...
Invention Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain. The...
Invention Diamine calcium channel blockers. Aromatic derivatives of aliphatic diamines are effective in ame...
2005 Invention Urea derivatives as calcium channel blockers. Urea derivatives of formula (1) which comprise pipe...
Invention T-type calcium channel splice variant compositions and methods. Cell proliferative conditions are...
Invention Diarylamine derivatives as calcium channel blockers. N-diarylaminoalkyl-substituted piperazine/4-...
Invention N-type calcium channel blockers. The present invention relates to 3-amino pyrrolidine derivatives...